SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 1.74 |
Enterprise Value ($M) | 1.62 |
Book Value ($M) | -2.59 |
Book Value / Share | -0.31 |
Price / Book | -0.67 |
NCAV ($M) | -2.66 |
NCAV / Share | -0.32 |
Price / NCAV | -0.65 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | n/a |
Return on Assets (ROA) | -5.42 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.35 |
Current Ratio | 0.45 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 2.12 |
Assets | 2.19 |
Liabilities | 4.78 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -11.99 |
Net Income | -9.89 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -10.57 |
Cash from Investing | 0.00 |
Cash from Financing | 10.70 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Armistice Capital, Llc | 4.99 | -28.91 | |
13G/A | Intracoastal Capital, Llc | 4.99 | 262.87 | |
13G/A | Hudson Bay Capital Management LP | 1.35 | -95.07 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Similar Companies | |
---|---|
BMMJ – Body and Mind Inc. | BMXMF – bioMérieux S.A. |
BOIRF – Boiron SA | BQST – BioQuest Corp. |
BSEM – BioStem Technologies, Inc. |
Financial data and stock pages provided by
Fintel.io